The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene
Abstract
Introduction of a normal retinoblastoma gene ( RB ) into retinoblastoma cells was previously shown to suppress several aspects of their neoplastic phenotype, including tumorigenicity in nude mice, thereby directly demonstrating a cancer suppression function of RB . To explore the possibility of a similar activity in a common adult tumor, RB expression was examined in three human prostate carcinoma cell lines. One of these, DU145, contained an abnormally small protein translated from an RB messenger RNA transcript that lacked 105 nucleotides encoded by exon 21. To assess the functional consequences of this mutation, normal RB expression was restored in DU145 cells by retrovirus-mediated gene transfer. Cells that maintained stable exogenous RB expression lost their ability to form tumors in nude mice, although their growth rate in culture was apparently unaltered. These results suggest that RB inactivation can play a significant role in the genesis of a common adult neoplasm and that restoration of normal RB -encoded protein in tumors could have clinical utility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn, M. E., Ks, N., Ohnuki, Y., Lechner, J. F., & Jones, L. W. (1979) · PubMed · Cited by 2,122
LNCaP model of human prostatic carcinoma.
Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H. E., Chu, T. M., MIRAND, E. A., & Murphy, G. P. (1983) · PubMed · Cited by 1,789
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Self-citationHuman Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
Self-citationWound Macrophages Express TGF-α and Other Growth Factors in Vivo: Analysis by mRNA Phenotyping
Rappolee, D. A., Mark, D., Banda, M. J., & Werb, Z. (1988) · Science · doi:10.1126/science.3041594 · Cited by 1,104
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
Buchkovich, K., Duffy, L. A., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90508-4 · Cited by 995
Chen, P.-L., Scully, P., Shew, J.-Y., Wang, J. Y. J., & Lee, W.-H. (1989) · Cell · doi:10.1016/0092-8674(89)90517-5 · Cited by 952
Self-citationIsolation of a human prostate carcinoma cell line (DU 145)
Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., & Paulson, D. F. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910210305 · Cited by 926
Cited by
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551
E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.
Durfee, T., Becherer, K., Chen, P. L., Yeh, S. H., Yang, Y., Kilburn, A. E., Lee, W. H., & Elledge, S. J. (1993) · Genes & Development · doi:10.1101/gad.7.4.555 · Cited by 1,451
Self-citationMice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
Self-citationReversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
Kaelin, W. G., Krek, W., Sellers, W. R., DeCaprio, J. A., Ajchenbaum, F., Fuchs, C. S., Chittenden, T., Li, Y., Farnham, P. J., Blanar, M. A., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90108-o · Cited by 819
Marshall, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90641-b · Cited by 751
Molecular genetics of prostate cancer
Abate-Shen, C., & Shen, M. M. (2000) · Genes & Development · doi:10.1101/gad.819500 · Cited by 735
Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., & Nadal-Ginard, B. (1993) · Cell · doi:10.1016/0092-8674(93)90110-c · Cited by 729
The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
Goodrich, D. W., Wang, N. P., Qian, Y.-W., Lee, E. Y.-H. P., & Lee, W.-H. (1991) · Cell · doi:10.1016/0092-8674(91)90181-w · Cited by 707
Self-citationHuman prostate cancer risk factors
Bostwick, D. G., Burke, H. B., Djakiew, D., Euling, S., Ho, S.-M., Landolph, J., Morrison, H., Sonawane, B., Shifflett, T., Waters, D. J., et al. (2004) · Cancer · doi:10.1002/cncr.20408 · Cited by 650
Chellappan, S., Kraus, V. B., Kroger, B., Munger, K., Howley, P. M., Phelps, W. C., & Nevins, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4549 · Cited by 614
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F
Helin, K., Lees, J. A., Vidal, M., Dyson, N., Harlow, E., & Fattaey, A. (1992) · Cell · doi:10.1016/0092-8674(92)90107-n · Cited by 613
Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Münger, K., Howley, P. M., & Moses, H. L. (1990) · Cell · doi:10.1016/0092-8674(90)90188-k · Cited by 609
The molecular biology of cancer
Bertram, J. S. (2000) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00007-8 · Cited by 585
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.
Hiebert, S. W., Chellappan, S. P., Horowitz, J. M., & Nevins, J. R. (1992) · Genes & Development · doi:10.1101/gad.6.2.177 · Cited by 576
Horowitz, J. M., Park, S. H., Bogenmann, E., Cheng, J. C., Yandell, D. W., Kaye, F. J., Minna, J. D., Dryja, T. P., & Weinberg, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2775 · Cited by 530
Genetic Mechanisms of Tumor Suppression by the Human p53 Gene
Chen, P.-L., Chen, Y., Bookstein, R., & Lee, W.-H. (1990) · Science · doi:10.1126/science.2274789 · Cited by 518
Self-citationKaelin, W. G., Pallas, D. C., DeCaprio, J. A., Kaye, F. J., & Livingston, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90236-r · Cited by 518
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.
Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M., Livingston, D., Dyson, N., & Harlow, E. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1111 · Cited by 514
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60862-3 · Cited by 510
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein.
Helin, K., Harlow, E., & Fattaey, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6501 · Cited by 472
How many mutations are required for tumorigenesis? implications from human cancer data
Balmain, A., Barrett, J. C., Moses, H., & Renan, M. J. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940070303 · Cited by 464
Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7
Lee, J.-O., Russo, A. A., & Pavletich, N. P. (1998) · Nature · doi:10.1038/36038 · Cited by 459
Allelic loss of chromosomes 16q and 10q in human prostate cancer.
Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I., & Isaacs, W. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8751 · Cited by 457
Chen, P. L., Riley, D. J., Chen, Y., & Lee, W. H. (1996) · Genes & Development · doi:10.1101/gad.10.21.2794 · Cited by 442
Self-citationThe retinoblastoma protein binds to a family of E2F transcription factors.
Lees, J. A., Saito, M., Vidal, M., Valentine, M., Look, T., Harlow, E., Dyson, N., & Helin, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7813 · Cited by 441
Expression of the Wilms' tumor gene WT1 in the murine urogenital system.
Pelletier, J., Schalling, M., Buckler, A. J., Rogers, A., Haber, D. A., & Housman, D. (1991) · Genes & Development · doi:10.1101/gad.5.8.1345 · Cited by 439
Bagchi, S., Weinmann, R., & Raychaudhuri, P. (1991) · Cell · doi:10.1016/0092-8674(91)90558-g · Cited by 426
Kowalik, T. F., DeGregori, J., Schwarz, J. K., & Nevins, J. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2491-2500.1995 · Cited by 418
Welch, P. (1993) · Cell · doi:10.1016/0092-8674(93)90497-e · Cited by 407
Chittenden, T., Livingston, D. M., & Kaelin, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90559-h · Cited by 407
Identification of a growth suppression domain within the retinoblastoma gene product.
Qin, X. Q., Chittenden, T., Livingston, D. M., & Kaelin, W. G. (1992) · Genes & Development · doi:10.1101/gad.6.6.953 · Cited by 404
The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.
Lees, J. A., Buchkovich, K. J., Marshak, D. R., Anderson, C. W., & Harlow, E. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb05006.x · Cited by 337
Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.
Bookstein, R., Rio, P., Madreperla, S. A., Hong, F., Allred, C., Grizzle, W. E., & Lee, W. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7762 · Cited by 334
Self-citationShan, B., Zhu, X., Chen, P. L., Durfee, T., Yang, Y., Sharp, D., & Lee, W. H. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5620 · Cited by 330
Self-citationPositive selection of candidate tumor-suppressor genes by subtractive hybridization.
Lee, S. W., Tomasetto, C., & Sager, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2825 · Cited by 319
Synergy of p53 and Rb Deficiency in a Conditional Mouse Model for Metastatic Prostate Cancer
Zhou, Z., Flesken-Nikitin, A., Corney, D. C., Wang, W., Goodrich, D. W., Roy-Burman, P., & Nikitin, A. Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0486 · Cited by 316
The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein.
Mancini, M. A., Shan, B., Nickerson, J. A., Penman, S., & Lee, W. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.418 · Cited by 315
Self-citationMittnacht, S., & Weinberg, R. A. (1991) · Cell · doi:10.1016/0092-8674(91)90456-9 · Cited by 311
The cell cycle and the retinoblastoma protein family
Ewen, M. E. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00690418 · Cited by 303
Howes, K. A., Ransom, N., Papermaster, D. S., Lasudry, J. G., Albert, D. M., & Windle, J. J. (1994) · Genes & Development · doi:10.1101/gad.8.11.1300 · Cited by 303
Lin, B. T., Gruenwald, S., Morla, A. O., Lee, W. H., & Wang, J. Y. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08018.x · Cited by 298
Self-citationSato, H., Kita, M., & Seiki, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49485-4 · Cited by 291
Negative regulation of human c-fos expression by thes retinoblastoma gene product
Robbins, P. D., Horowitz, J. M., & Mulligan, R. C. (1990) · Nature · doi:10.1038/346668a0 · Cited by 287
Williams, B. O., Schmitt, E. M., Remington, L., Bronson, R. T., Albert, D. M., Weinberg, R. A., & Jacks, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06745.x · Cited by 284
Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells.
Houle, B., Rochette-Egly, C., & Bradley, W. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.985 · Cited by 280
The melanoma differentiation associated gene mda-7 suppresses cancer cell growth.
Jiang, H., Su, Z. Z., Lin, J. J., Goldstein, N. I., Young, C. S., & Fisher, P. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9160 · Cited by 278
Harrington, E. A., Fanidi, A., & Evan, G. I. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90100-7 · Cited by 265
Stanbridge, E. J. (1990) · Annual Review of Genetics · doi:10.1146/annurev.ge.24.120190.003151 · Cited by 259
Hypoxia Increases Androgen Receptor Activity in Prostate Cancer Cells
Park, S.-Y., Kim, Y.-J., Gao, A. C., Mohler, J. L., Onate, S. A., Hidalgo, A. A., Ip, C., Park, E.-M., Yoon, S. Y., & Park, Y.-M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1341 · Cited by 81
Billecke, C. A., Ljungman, M. E., McKay, B. C., Rehemtulla, A., Taneja, N., & Ethier, S. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205546 · Cited by 28
Metadata
- Authors
- Bookstein, R., Shew, J.-Y., Chen, P.-L., Scully, P., & Lee, W.-H.
- Venue
- Science
- Published
- 1990-02-09
- Volume
- 247
- Issue
- 4943
- Pages
- 712-715
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2072320617
- Cited by
- 591
- References
- 33
- FWCI
- 31.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.